Advertisement

AIDS and Behavior

, Volume 15, Issue 7, pp 1561–1569 | Cite as

High-Risk Behaviors Associated with Injection Drug Use Among Recently HIV-Infected Men Who Have Sex with Men in San Diego, CA

  • Angie Ghanem
  • Susan J. Little
  • Lydia Drumright
  • Lin Liu
  • Sheldon Morris
  • Richard S. GarfeinEmail author
Original Paper

Abstract

The contribution of injection drug use to HIV risk among men who have sex with men (MSM) is understudied. MSM infected with HIV within the prior 12 months completed a questionnaire assessing sociodemographic, sexual, drug use, and social factors. Analyses were performed to identify factors associated with lifetime history of injection drug use. Among 212 participants, the mean age was 33.8 years, 72% were White, 89% had attended college, and 9.4% reported ever injecting drugs. In multivariable logistic regression analysis, ever trading sex and using methamphetamine during sex with at least one of their last three partners were associated with injection drug use. Adjusting for these variables, in separate models, ever perpetrating violence against others (Adjusted Odds Ratio [AOR] = 3.16), having physically abusive sexual partners (AOR = 3.08), or physically abusing sexual partners (AOR = 10.17) were significantly (P < 0.05) associated with injection drug use. These findings suggest that violence is more common among MSM who inject drugs, which should be considered in HIV prevention efforts.

Keywords

MSM Injection drug use Violence HIV-risk Sexual behavior 

Resumen

La contribución del uso de drogas inyectables al riesgo de contraer el VIH en los hombres que tienen relaciones sexuales con hombres (HSH) no ha sido investigada lo suficiente. HSH infectados con el VIH en los 12 meses anteriores contestaron un cuestionario que medía factores sociodemográficos, sexuales, de uso de drogas y sociales. Se realizaron análisis para identificar los factores relacionados con el historial de uso de drogas inyectables. Entre los 212 participantes, la edad promedio fue de 33.8 años, el 72% era caucásico, el 89% había asistido a la universidad y el 9.4% reportó haberse inyectado drogas alguna vez. En un análisis multivariado de regresión logística, estuvieron relacionados con el uso de drogas inyectables el haber intercambiado sexo alguna vez y el haber usado metanfetaminas durante el coito con al menos 1 de sus tres últimas parejas. Ajustando estas variables, en modelos por separado, estuvieron significativamente (P < 0.05) relacionados con el uso de drogas inyectables el haber perpetrado violencia contra los demás (“Adjusted Odds Ratio” [AOR] = 3.16), el tener parejas sexuales físicamente abusivas (AOR = 3.08) o el físicamente maltratar a las parejas sexuales (AOR = 10.17). Estos hallazgos sugieren que la violencia es más común entre los HSH quienes se inyectan drogas, lo cual debe tomarse en cuenta en los esfuerzos para la prevención del VIH.

Notes

Acknowledgments

The authors would like to acknowledge and thank Tari Gilbert, Paula Potter, Joanne Santangelo, and the University of California, San Diego Antiviral Research Center staff for their support in data collection. Most of all we would like to thank our participants for volunteering for this study. This work was supported by UCSD Center for AIDS Research (AI36214), AI43638, AI074621 from the National Institutes of Health, and RN07-SD-702 from the California HIV Research Program (CHRP).

References

  1. 1.
    Centers for Disease Control and Prevention. HIV and AIDS among gay and bisexual men. CDC Fact Sheet August 2009. Atlanta, GA: Centers for Disease Control and Prevention; 2009.Google Scholar
  2. 2.
    Celentano DD, Latimore AD, Mehta SH. Variations in sexual risks in drug users: emerging themes in a behavioral context. Curr HIV/AIDS Rep. 2008;5(4):212–8.PubMedCrossRefGoogle Scholar
  3. 3.
    Centers for Disease Control and Prevention. HIV surveillance report, 2008; vol. 20. Published June 2010. Accessed Sept 2010.Google Scholar
  4. 4.
    Kral AH, Bluthenthal RN, Lorvick J, Gee L, Bacchetti P, Edlin BR. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet. 2001;357(9266):1397–401.PubMedCrossRefGoogle Scholar
  5. 5.
    Strathdee SA, Galai N, Safaiean M, Celentano DD, Vlahov D, Johnson L, et al. Sex differences in risk factors for HIV seroconversion among injection drug users: a 10-year perspective. Arch Intern Med. 2001;161(10):1281–8.PubMedCrossRefGoogle Scholar
  6. 6.
    Rietmeijer CA, Wolitski RJ, Fishbein M, Corby NH, Cohn DL. Sex hustling, injection drug use, and non-gay identification by men who have sex with men. Associations with high-risk sexual behaviors and condom use. Sex Transm Dis. 1998;25(7):353–60.PubMedCrossRefGoogle Scholar
  7. 7.
    Newman PA, Rhodes F, Weiss RE. Correlates of sex trading among drug-using men who have sex with men. Am J Public Health. 2004;94(11):1998–2003.PubMedCrossRefGoogle Scholar
  8. 8.
    Maslow CB, Friedman SR, Perlis TE, Rockwell R, Des Jarlais DC. Changes in HIV seroprevalence and related behaviors among male injection drug users who do and do not have sex with men: New York City, 1990–1999. Am J Public Health. 2002;92(3):382–4.PubMedCrossRefGoogle Scholar
  9. 9.
    Ibanez GE, Purcell DW, Stall R, Parsons JT, Gomez CA. Sexual risk, substance use, and psychological distress in HIV-positive gay and bisexual men who also inject drugs. AIDS. 2005;19(Suppl 1):S49–55.PubMedCrossRefGoogle Scholar
  10. 10.
    Semple SJ, Patterson TL, Grant I. A comparison of injection and non-injection methamphetamine-using HIV positive men who have sex with men. Drug Alcohol Depend. 2004;76(2):203–12.PubMedCrossRefGoogle Scholar
  11. 11.
    Colfax GN, Buchbinder SP, Cornelisse PGA, Vittinghoff E, Mayer K, Celum C. Sexual risk behaviors and implications for secondary HIV transmission during and after HIV seroconversion. AIDS. 2002;16(11):1529.PubMedCrossRefGoogle Scholar
  12. 12.
    Pilcher CD, Tien HC, Eron JJ Jr, Vernazza PL, Leu SY, Stewart PW, et al. Brief but efficient: acute HIV infection and the sexual transmission of HIV. J Infect Dis. 2004;189:1785–92.PubMedCrossRefGoogle Scholar
  13. 13.
    Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. N Engl J Med. 2000;342(13):921.PubMedCrossRefGoogle Scholar
  14. 14.
    Little SJ, Holte S, Routy JP, Daar ES, Markowitz M, Collier AC, et al. Antiretroviral-drug resistance among patients recently infected with HIV. N Engl J Med. 2002;347(6):385.PubMedCrossRefGoogle Scholar
  15. 15.
    Hecht FM, Wang L, Collier A, Little S, Markowitz M, Margolick J, et al. A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection. J Infect Dis. 2006;194:725–33.PubMedCrossRefGoogle Scholar
  16. 16.
    Centers for Disease Control and Prevention. Intimate partner violence: consequences. Atlanta, GA: Centers for Disease Control and Prevention; 2009.Google Scholar
  17. 17.
    Greenwood GL, Relf MV, Huang B, Pollack LM, Canchola JA, Catania JA. Battering victimization among a probability-based sample of men who have sex with men. Am J Public Health. 2002;92(12):1964–9.PubMedCrossRefGoogle Scholar
  18. 18.
    Stall R, Mills TC, Williamson J, Hart T, Greenwood G, Paul J, et al. Association of co-occurring psychosocial health problems and increased vulnerability to HIV/AIDS among urban men who have sex with men. Am J Public Health. 2003;93(6):939–42.PubMedCrossRefGoogle Scholar
  19. 19.
    Koblin BA, Torian L, Xu G, Guilin V, Makki H, Mackellar D, et al. Violence and HIV-related risk among young men who have sex with men. AIDS Care. 2006;18(8):961–7.PubMedCrossRefGoogle Scholar
  20. 20.
    Bogart LM, Collins RL, Cunningham W, Beckman R, Golinelli D, Eisenman D, et al. The association of partner abuse with risky sexual behaviors among women and men with HIV/AIDS. AIDS Behav. 2005;9(3):325–33.PubMedCrossRefGoogle Scholar
  21. 21.
    Houston E, McKirnan DJ. Intimate partner abuse among gay and bisexual men: risk correlates and health outcomes. J Urban Health. 2007;84(5):681–90.PubMedCrossRefGoogle Scholar
  22. 22.
    Frye V, Latka MH, Wu Y, Valverde EE, Knowlton AR, Knight KR, et al. Intimate partner violence perpetration against main female partners among HIV-positive male injection drug users. J Acquir Immune Defic Syndr. 2007;46(Suppl 2):S101–9.PubMedGoogle Scholar
  23. 23.
    Marshall BDL, Fairbairn N, Li K, Wood E, Kerr T. Physical violence among a prospective cohort of injection drug users: a gender-focused approach. Drug Alcohol Depend. 2008;97(3):237–46.PubMedCrossRefGoogle Scholar
  24. 24.
    Stall R, Purcell DW. Intertwining epidemics: a review of research on substance use among men who have sex with men and its connection to the AIDS epidemic. AIDS Behav. 2000;4(2):181–92.CrossRefGoogle Scholar
  25. 25.
    Bull SS, Piper P, Rietmeijer C. Men who have sex with men and also inject drugs-profiles of risk related to the synergy of sex and drug injection behaviors. J Homosex. 2002;42(3):31–51.PubMedCrossRefGoogle Scholar
  26. 26.
    Inglez-Dias A, Hahn JA, Lum PJ, Evans J, Davidson P, Page-Shafer K. Trends in methamphetamine use in young injection drug users in San Francisco from 1998 to 2004: the UFO Study. Drug Alcohol Rev. 2008;27(3):286–91.PubMedCrossRefGoogle Scholar
  27. 27.
    Buchacz K, McFarland W, Kellogg TA, Loeb L, Holmberg SD, Dilley J, et al. Amphetamine use is associated with increased HIV incidence among men who have sex with men in San Francisco. AIDS. 2005;19(13):1423–4.PubMedCrossRefGoogle Scholar
  28. 28.
    Drumright LN, Patterson TL, Strathdee SA. Club drugs as causal risk factors for HIV acquisition among men who have sex with men: a review. Subst Use Misuse. 2006;41(10–12):1551–601.PubMedCrossRefGoogle Scholar
  29. 29.
    Koblin BA, Husnik MJ, Colfax G, Huang Y, Madison M, Mayer K, et al. Risk factors for HIV infection among men who have sex with men. AIDS. 2006;20(5):731–9.PubMedCrossRefGoogle Scholar
  30. 30.
    Chesney MA, Barrett DC, Stall R. Histories of substance use and risk behavior: precursors to HIV seroconversion in homosexual men. Am J Public Health. 1998;88(1):113–6.PubMedCrossRefGoogle Scholar
  31. 31.
    Hirshfield S, Remien RH, Humberstone M, Walavalkar I, Chiasson MA. Substance use and high-risk sex among men who have sex with men: a national online study in the USA. AIDS Care. 2004;16(8):1036–47.PubMedCrossRefGoogle Scholar
  32. 32.
    Schwarcz S, Scheer S, McFarland W, Katz M, Valleroy L, Chen S, et al. Prevalence of HIV infection and predictors of high-transmission sexual risk behaviors among men who have sex with men. Am J Public Health. 2007;97(6):1067–75.PubMedCrossRefGoogle Scholar
  33. 33.
    Frosch D, Shoptaw S, Huber A, Rawson RA, Ling W. Sexual HIV risk among gay and bisexual male methamphetamine abusers. J Subst Abuse Treat. 1996;13(6):483–6.PubMedCrossRefGoogle Scholar
  34. 34.
    Knight KR, Purcell D, Dawson-Rose C, Halkitis PN, Gomez CA, Seropositive Urban Injectors Study Team. Sexual risk taking among HIV-positive injection drug users: contexts, characteristics, and implications for prevention. AIDS Educ Prev. 2005;17(1 Suppl A):76–88.PubMedCrossRefGoogle Scholar
  35. 35.
    Doherty MC, Garfein RS, Monterroso E, Brown D, Vlahov D. Correlates of HIV infection among young adult short-term injection drug users. AIDS. 2000;14(6):717–26.PubMedCrossRefGoogle Scholar
  36. 36.
    Kuyper LM, Lampinen TM, Li K, Spittal PM, Hogg RS, Schechter MT, et al. Factors associated with sex trade involvement among male participants in a prospective study of injection drug users. Sex Transm Infect. 2004;80(6):531–5.PubMedCrossRefGoogle Scholar
  37. 37.
    Jarlais DCD, Paone D, Milliken J, Turner CF, Miller H, Gribble J, et al. Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomised trial. Lancet. 1999;353(9165):1657–61.PubMedCrossRefGoogle Scholar
  38. 38.
    Turner CF, Ku L, Rogers SM, Lindberg LD, Pleck JH, Sonenstein FL. Adolescent sexual behavior, drug use, and violence: increased reporting with computer survey technology. Science. 1998;280(5365):867.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Angie Ghanem
    • 1
  • Susan J. Little
    • 2
  • Lydia Drumright
    • 3
  • Lin Liu
    • 4
  • Sheldon Morris
    • 2
  • Richard S. Garfein
    • 2
    Email author
  1. 1.Graduate School of Public HealthSan Diego State UniversitySan DiegoUSA
  2. 2.Department of Medicine, School of MedicineUniversity of California San DiegoSan DiegoUSA
  3. 3.Centre for Infection Prevention and Management, Department of MedicineImperial College of LondonLondonUK
  4. 4.Department of Family & Preventive Medicine, School of MedicineUniversity of California San DiegoSan DiegoUSA

Personalised recommendations